MediPharm Labs Corp.
MediPharm Labs Corp. (LABS.TO) Revenue
Annual & quarterly revenue history · segment & region breakdown
LABS.TO · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsMediPharm Labs Corp. trailing twelve-month (TTM) revenue is $0.04B, an increase of 7.54% year-over-year from $0.05B in FY2025.
Revenue trend
2025 – 2016 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.05B | +$0.00B | +7.54% |
| 2024-12-31 | $0.04B | +$0.01B | +26.92% |
| 2023-12-31 | $0.03B | +$0.01B | +49.49% |
| 2022-12-31 | $0.02B | +$0.00B | +1.87% |
| 2021-12-31 | $0.02B | -$0.01B | -39.71% |
| 2020-12-31 | $0.04B | -$0.09B | -72.14% |
| 2019-12-31 | $0.13B | +$0.12B | +1167.42% |
| 2018-12-31 | $0.01B | +$0.01B | — |
| 2017-12-31 | $0.00B | +$0.00B | — |
| 2016-12-31 | $0.00B | — | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income MediPharm Labs Corp. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
MediPharm Labs Corp. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in CAD.
Data sourced from MediPharm Labs Corp.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
LABS.TO revenue · 4 questionsLABS.TO's trailing twelve-month (TTM) revenue is $0.04B. That is an increase of 7.54% year-over-year from $0.05B in FY2025.
▸ Source: FMP · MediPharm Labs Corp. SEC filings · GAAP · MediPharm Labs Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026